Legend Biotech Corp ADR (LEGN)
Industry Biotechnology
This stock can be held in an Investment Account
Sell
$22.20
Buy
$22.89
$-0.69 (-3.00%)
Prices updated at 12 Dec 2025, 09:33 EST
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 285m | 627m | |
| 141m | 393m | |
| -439m | -303m | |
| -154.13 | -48.35 | |
| -518m | -177m | |
| -478m | -113m | |
| Sales, General and administrative | 201m | 284m |
| Interest expenses | 22m | 22m |
| Provision for income taxes | -2m | 19m |
| Operating expenses | 580m | 696m |
| Income before taxes | -520m | -158m |
| Net income available to common shareholders | -518m | -177m |
| -2.94 | -0.96 | |
| Net interest income | 33m | 40m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -2.94 | -0.96 |
| Free cash flow per share | -2.1573 | -0.9656 |
| Book value/share | 7.3642 | 6.0774 |
| Debt equity ratio | 0.260112 | 0.332334 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 1,498m | 1,284m |
| Current liabilities | 216m | 278m |
| Total capital | 1,533m | 1,342m |
| Total debt | 329m | 351m |
| Total equity | 1,251m | 1,041m |
| Total non current liabilities | - | - |
| Loans | 281m | 301m |
| Total assets | 1,849m | 1,670m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,278m | 287m |
| Common stock | 364m | 367m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 786m | 1,278m |
| Cash dividends paid | - | - |
| -416m | -158m | |
| Investments (gains) losses | 93m | -851m |
| 1,278m | 287m | |
| Net income | - | - |
| -393m | -144m | |
| -23m | -14m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
